Vanda Pharmaceuticals (VNDA) – Analyst EPS View
-
UPDATE: BofA Securities Starts Vanda Pharmaceuticals (VNDA) at Buy Upside to Come From Under the Radar Candidates
-
Vanda Pharmaceuticals (VNDA) PT Lowered to $21 at Oppenheimer
-
-
-
-
-
-
-
Back to VNDA Stock Lookup